透過您的圖書館登入
IP:3.144.44.228

摘要


膀胱過動症為一症候群,診斷以臨床症狀為主,需排除泌尿道感染或神經學相關疾病,主要症狀是急尿,亦可伴隨著頻尿、急迫性尿失禁或夜尿等症狀。除第一線行為治療外,目前臨床仍以第二線藥物治療為主,傳統治療藥物以抗膽鹼藥物為大宗,後期有一新藥的引進,即Beta-3腎上腺接受體作用劑(β-3 agonist),較無抗膽鹼藥物所引起的相關副作用。近日美國食品藥物管理局(FDA)發表聲明,針對臨床上較為嚴重的膀胱過動症患者,合併上述兩種藥物治療可以達到更好的效果。

參考文獻


2. Ryan GL, Syrop CH, Van Voorhis BJ. Role, epidemiology, and natural history of benign uterine mass lesions. Clin Obstet Gynecol 2005;48:312-24.
4. Hanafi M. Predictors of leiomyoma recurrence after myomectomy. Obstet Gynecol 2005;105:877-81.
5. Bhave Chittawar P, Franik S, Pouwer AW, et al. Minimally invasive surgical techniques versus open myomectomy for uterine fibroids. Cochrane Database Syst Rev 2014:Cd004638.
6. Lewis EI, Srouji SS, Gargiulo AR. Robotic single-site myomectomy: initial report and technique. Fertil Steril 2015;103:1370-7.e1.
7. Lethaby A, Puscasiu L, Vollenhoven B. Preoperative medical therapy before surgery for uterine fibroids. Cochrane Database Syst 2017;11:Cd000547.

延伸閱讀